BREAKING: U.S. Cuts Deal to Provide 15-Minute COVID-19 At-Home Tests

Ellume, an Australian company that manufactures a 15-minute at-home test for the coronavirus, has agreed to a $231.8 million deal with the Biden administration has made a $231.8 million deal with an Australian company to boost availability of the first at-home rapid test for the coronavirus.

The Ellume test, which is available without a prescription, can send results to a smartphone within 15 minutes of receiving a sample.

The Food and Drug Administration gave emergency authorization to Ellume’s rapid test in December, after it showed 96% accuracy in a U.S. clinical study. Those trials included both adults and children of ages 2 years and older.

Read the full story via NPR.

X Facebook LinkedIn Email Flipboard Pinterest Reddit SMS WhatsApp

Why Crisis Management Preparedness Matters

By Everbridge: Almost 70 percent of leaders have dealt with a corporate crisis in the last five years, PricewaterhouseCoopers (PwC) found in its 2019 Global Crisis Survey. And, according to …

Implementing a Mobile Solution – One BCP Mobile App’s Journey

By Maya Calabrese and Andy Waples, Eaton Vance Management: From developing the strategy to setting the scope to assessing internal resources and planning the implementation and rollout, there are countless …

Staying Above Water: A Systemic Response To Rising Flood Risk

Flood risk is growing at an alarming rate across the world, posing increasingly complex challenges to socioeconomic systems, infrastructure, and the environment. According to Marsh McLennan estimates, 18% of the …